Table 3.

Multivariate analysis of pCR.

Variable	Effect	OR (95% CI)	P
Treatment	Nab-paclitaxel vs docetaxel	2.777 (1.292–5.969)	0.009
Tumor size	T1–2 vs T3–4	1.399 (0.658–2.973)	0.382
Grade	I–II vs III	1.068 (0.506–2.254)	0.864
Lymph node status	Positive vs negative	0.459 (0.215–0.979)	0.044
Tumor subtype	HR+/HER2- vs HR-/HER2-	0.375 (0.174–0.808)	0.012